Catalyst Wire Dossier Catalyst Wire Dossier

EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

efavirenz, lamivudine and tenofovir disoproxil fumarate · Laurus Labs Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE, covering 2020-05-14 to 2020-05-14. Get the full timeline:

Most recent: FDA Approved: EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)

See pricing